Committed to the Quest to Cure Cancer

Therapeutic Depth:CNS

Our in-depth oncology trial knowledge spans the entire clinical process, from design and execution of proof of concept trials to regulatory approval, and includes a long history in immunotherapy trials. 85 percent of our project management team has oncology experience, and our client medical advisor has two decades of experience in all phases of oncology drug development, including global, clinical programs and international regulatory authorities.

We have a particular depth of expertise in early phase oncology research as well. The strong relationships we’ve developed with oncology investigative sites supports your mission to advance treatments in this critical area of research.

Every project is unique, and we treat it accordingly. We offer cost-effective data management solutions particularly suited to early phase and innovative oncology trials.

SynteractHCR oncology expertise includes:

  • Advanced Cancer
  • Anaplastic Thyroid Carcinoma
  • Bladder Cancer
  • Brain Metastases/ Glioblastoma Multiforme
  • Breast Cancer
  • Cancer Pain
  • Cancer Vaccines with Dendritic cells
  • Carcinoid Syndrome
  • Cervical Dysplasia
  • Chronic Idiopathic Myelofibrosis
  • Cell Therapy
  • Chemotherapy
  • Colorectal Cancer
  • Gastrointestinal Cancer
  • Head and Neck Cancer
  • Kaposi Sarcoma
  • Leukemia
  • Liver Cancer
  • Lung Cancer/NSCLC
  • Lymphoma/NHL
  • Melanoma
  • Multiple Myeloma
  • Myeloid Malignancies
  • Oesteosarcoma
  • Oncolytic viruses
  • Ovarian
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Solid Tumor

Related Links

Well-rounded experience.

SynteractHCR has conducted
trials across all major
therapeutic areas and
we have contributed 
to more than 230
product approvals
since our
founding.
Learn More

Contact SynteractHCR

  • USA: +1 760 268 8200
  • Europe: +49 89 12 66 80 0
  • Contact Form...

Contact SynteractHCR

Tell us how to stay in touch with you:


Required Fields(*)
Cancel